21
Participants
Start Date
April 30, 2016
Primary Completion Date
January 26, 2022
Study Completion Date
January 26, 2022
Anakinra 100mg and Placebo Depo-Medrone
Anakinra 100mg injection S/C Day 1 to Day 5 and Placebo Depo-Medrone (Lipofundin 3mL) I/M Day 1. Anakinra is an interleukin-1 receptor antagonist. Placebo for Depo-Medrone placebo is Lipofundin MCT/LCT 10%.
Depo-Medrone 120mg and Placebo (Anakinra)
Depo-Medrone 120mg in 3mL. Placebo for Anakinra supplied from manufacturer. 120mg Depo-Medrone I/M Day 1 and Placebo Anakinra 100mg injection S/C Day 1 to Day 5.
Southend Hospital, Southend-on-Sea
Anglia Ruskin University
OTHER
University of East Anglia
OTHER
University of Essex
OTHER
National Institute for Health Research, United Kingdom
OTHER_GOV
Mid and South Essex NHS Foundation Trust
OTHER